One third of gliosarcoma (WHO grade IV) and half of giant cell glioblastoma (WHO grade IV) samples were GAL1-R-positive (≤1% of tumor cells; Figures 5E,H). This evidence concerns the gene GAL and giant cell glioblastoma.